• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SR 48968对豚鼠离体主支气管胆碱能神经传递的抑制作用

Inhibition of cholinergic neurotransmission in isolated guinea-pig main bronchi by SR 48968.

作者信息

Martin C A, Emonds-Alt X, Advenier C

机构信息

Laboratoire de Pharmacologie, Faculté de Médecine Paris-Ouest, France.

出版信息

Eur J Pharmacol. 1993 Oct 26;243(3):309-12. doi: 10.1016/0014-2999(93)90192-k.

DOI:10.1016/0014-2999(93)90192-k
PMID:8276085
Abstract

SR 48968 (10(-6) to 10(-5) M) inhibited the cholinergic response of the isolated guinea-pig main bronchus to electrical field stimulation. Since this effect was reversed by naloxone 10(-5) M and since SR 48968 had no effect on the contractile response to exogenous acetylcholine, we conclude that SR 48968 acts at a prejunctional level and that opioid receptors are involved. This effect was observed at concentrations approximately 75,000 times higher than those needed for blockade of tachykinin NK2 receptors.

摘要

SR 48968(10⁻⁶至10⁻⁵M)可抑制离体豚鼠主支气管对电场刺激的胆碱能反应。由于该效应可被10⁻⁵M的纳洛酮逆转,且SR 48968对外源性乙酰胆碱的收缩反应无影响,我们得出结论:SR 48968作用于神经节前水平,且涉及阿片受体。在比阻断速激肽NK2受体所需浓度高约75000倍的浓度下观察到了这种效应。

相似文献

1
Inhibition of cholinergic neurotransmission in isolated guinea-pig main bronchi by SR 48968.SR 48968对豚鼠离体主支气管胆碱能神经传递的抑制作用
Eur J Pharmacol. 1993 Oct 26;243(3):309-12. doi: 10.1016/0014-2999(93)90192-k.
2
Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.速激肽受体选择性激动剂对胆碱能神经传递的促进作用:种属差异的证据。
Br J Pharmacol. 1994 Jan;111(1):103-10. doi: 10.1111/j.1476-5381.1994.tb14030.x.
3
Influence of (+/-)-CP-96,345 and SR 48968 on electrical field stimulation of the isolated guinea-pig main bronchus.
Eur J Pharmacol. 1992 Dec 2;224(2-3):137-43. doi: 10.1016/0014-2999(92)90797-8.
4
Modulation of cholinergic neurotransmission in guinea-pig airways by opioids.阿片类药物对豚鼠气道胆碱能神经传递的调节作用。
Br J Pharmacol. 1990 May;100(1):131-7. doi: 10.1111/j.1476-5381.1990.tb12064.x.
5
SR 48968, a novel non-peptide tachykinin NK-2-receptor antagonist, selectively inhibits the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.SR 48968,一种新型非肽类速激肽NK-2受体拮抗剂,可选择性抑制豚鼠离体支气管肌肉非胆碱能介导的神经源性收缩。
J Pharm Pharmacol. 1993 Dec;45(12):1037-41. doi: 10.1111/j.2042-7158.1993.tb07176.x.
6
Postjunctional inhibitory effect of the NK2 receptor antagonist, SR 48968, on sensory NANC bronchoconstriction in the guinea-pig.NK2受体拮抗剂SR 48968对豚鼠感觉性非肾上腺素能非胆碱能支气管收缩的接头后抑制作用。
Br J Pharmacol. 1993 Jul;109(3):765-73. doi: 10.1111/j.1476-5381.1993.tb13640.x.
7
Neurotensin modulates cholinergic and noncholinergic neurotransmission in guinea-pig main bronchi in vitro.神经降压素在体外调节豚鼠主支气管中的胆碱能和非胆碱能神经传递。
Neuropeptides. 1994 Mar;26(3):159-66. doi: 10.1016/0143-4179(94)90125-2.
8
Non-specific actions of the non-peptide tachykinin receptor antagonists, CP-96,345, RP 67580 and SR 48968, on neurotransmission.非肽类速激肽受体拮抗剂CP-96,345、RP 67580和SR 48968对神经传递的非特异性作用。
Br J Pharmacol. 1994 Jan;111(1):179-84. doi: 10.1111/j.1476-5381.1994.tb14041.x.
9
Effects of two beta 3-adrenoceptor agonists, SR 58611A and BRL 37344, and of salbutamol on cholinergic and NANC neural contraction in guinea-pig main bronchi in vitro.两种β3 -肾上腺素能受体激动剂SR 58611A和BRL 37344以及沙丁胺醇对豚鼠离体主支气管胆碱能和非肾上腺素能非胆碱能神经收缩的影响。
Br J Pharmacol. 1993 Dec;110(4):1311-6. doi: 10.1111/j.1476-5381.1993.tb13961.x.
10
Morphine and opioid peptides selectively inhibit the non-cholinergically mediated neurogenic contraction of guinea-pig isolated bronchial muscle.吗啡和阿片肽可选择性抑制豚鼠离体支气管肌肉的非胆碱能介导的神经源性收缩。
J Pharm Pharmacol. 1990 Mar;42(3):214-6. doi: 10.1111/j.2042-7158.1990.tb05393.x.

引用本文的文献

1
Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome.用于治疗肠易激综合征的速激肽NK2受体拮抗剂。
Br J Pharmacol. 2004 Apr;141(8):1249-63. doi: 10.1038/sj.bjp.0705751. Epub 2004 Mar 22.